A.R.T. Advisors’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

A.R.T. Advisors’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-11,648	Closed	-$149K	–	1751
2018 Q4	$149K	Buy	+11,648	New	+$177K	0.01%	1116
2017 Q2	–	Sell	-10,022	Closed	-$155K	–	1848
2017 Q1	$155K	Buy	+10,022	New	+$143K	0.01%	1213

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

A.R.T. Advisors's OXFD Position: Q1 2019 in Review

A.R.T. Advisors sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2019, closing a stake of 11,648 shares — an estimated $149K sold.

A.R.T. Advisors first reported a position in OXFD in Q1 2017 and held it in 2 quarters. The position peaked at $155K in Q1 2017. 92 funds tracked by Wall St. Rank hold OXFD as of Q1 2019.

A.R.T. Advisors reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2019 after selling out during the quarter.
A.R.T. Advisors sold 11,648 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2019, an estimated $149K.
A.R.T. Advisors first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2017 and held it in 2 quarters.
A.R.T. Advisors's Oxford Immunotec Global PLC Ordinary Shares position peaked at $155K in Q1 2017.
92 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2019.

Based on A.R.T. Advisors's 13F filing for Q1 2019, filed 15 May 2019.